Marker Therapeutics Inc. (MRKR) |
|
2.56 -0.1 (-3.76%)
|
02-25 16:00 |
|
Open: |
2.67 |
Pre. Close: |
2.66 |
|
High:
|
2.755 |
Low:
|
2.53 |
|
Volume:
|
194,974 |
Market Cap:
|
117M |
|
|
|
|
Marker Therapeutics, Inc., a clinical stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. Its MultiTAA T cell technology is based on the expansion of non-engineered tumor-specific T cells that recognize tumor associated antigens and kill tumor cells expressing those targets. The company's MultiTAA T cell therapies include autologous T cells for the treatment of lymphoma, multiple myeloma, and various solid tumors; and allogeneic T cells for the treatment of acute myeloid leukemia and acute lymphoblastic leukemia. It is also developing TPIV100/110, which is in Phase II clinical trial to treat breast cancer; and TPIV200 that is in Phase II clinical trial for the treatment of breast and ovarian cancers. In addition, the company is developing PolyStart, a proprietary nucleic acid-based antigen expression techno |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
2.763 - 2.786 |
2.786 - 2.801 |
|
Low:
|
2.486 - 2.509 |
2.509 - 2.525 |
|
Close:
|
2.529 - 2.566 |
2.566 - 2.59 |
|
Technical analysis |
as of: 2020-02-25 4:31:40 PM |
|
Overall:
|
 |
| Stoxline posted a SELL today, same as yesterday. Downward movement continues. |
| Target: |
Six months: 3.54 One year: 3.96 |
| Support: |
Support1: 2.45 Support2: 2.04 |
| Resistance: |
Resistance1: 3.03 Resistance2: 3.39 |
| Pivot: |
2.77  |
| Moving Average: |
MA(5): 2.68 MA(20): 2.74
MA(100): 3.34 MA(250): 4.89 |
| MACD: |
MACD(12,26): -0.08 Signal(9): -0.08 |
| Stochastic oscillator: |
%K(14,3): 19.74 %D(3): 26.58 |
| RSI: |
RSI(14): 38.92 |
| 52-week: |
High: 9.17 Low: 2.45 Change(%): -59.7 |
| Average Vol(K): |
3-Month: 31584 10-Days: 29892 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.MRKR has closed above bottom band by 3.0%. Bollinger Bands are 54% narrower than normal. The narrow width of the bands suggests low volatility as compared to MRKR's normal range. The bands have been in this narrow range for 7 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Headline News |
|
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
|
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
 |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
 |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
